ORBIMED ADVISORS LLC Q4 2019 Filing
Filed February 14, 2020
Portfolio Value
$7.0B
Holdings
135
Report Date
Q4 2019
Filing Type
13F-HR
All Holdings (135 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ASNDASCENDIS PHARMA A S | 3,343,100 | $465.1B | 6640.06% | |
| 2 | —SYNTHORX INC | 5,316,355 | $371.6B | 5304.71% | |
| 3 | 1T7TRICIDA INC | 9,614,280 | $362.8B | 5180.26% | |
| 4 | SWTXSPRINGWORKS THERAPEUTICS INC | 7,406,307 | $285.1B | 4069.89% | |
| 5 | —PREVAIL THERAPEUTICS INC | 13,822,463 | $218.8B | 3123.92% | |
| 6 | BSXBOSTON SCIENTIFIC CORP | 4,674,800 | $211.4B | 3018.04% | |
| 7 | ALECALECTOR INC | 10,987,944 | $189.3B | 2702.93% | |
| 8 | ALXNALEXION PHARMACEUTICALS INC | 1,662,585 | $179.8B | 2567.11% | |
| 9 | MRKMERCK & CO INC | 1,954,100 | $177.7B | 2537.36% | |
| 10 | MRTXEURMIRATI THERAPEUTICS INC | 1,340,600 | $172.8B | 2466.33% | |
| 11 | VRTXVERTEX PHARMACEUTICALS INC | 783,100 | $171.5B | 2447.91% | |
| 12 | —TURNING POINT THERAPEUTICS I | 2,745,327 | $171.0B | 2441.43% | |
| 13 | IOVAIOVANCE BIOTHERAPEUTICS INC | 5,548,326 | $153.6B | 2192.61% | |
| 14 | NXTCNEXTCURE INC | 2,711,013 | $152.7B | 2180.24% | |
| 15 | HUMHUMANA INC | 391,900 | $143.6B | 2050.72% | |
| 16 | BMYBRISTOL MYERS SQUIBB CO | 1,700,000 | $109.1B | 1557.93% | |
| 17 | EHTHEHEALTH INC | 1,111,914 | $106.8B | 1525.24% | |
| 18 | ETNBGBP89BIO INC | 4,004,442 | $105.3B | 1503.03% | |
| 19 | EWEDWARDS LIFESCIENCES CORP | 434,900 | $101.5B | 1448.50% | |
| 20 | NBIXNEUROCRINE BIOSCIENCES INC | 935,970 | $100.6B | 1436.35% | |
| 21 | CICIGNA CORP NEW | 489,700 | $100.1B | 1429.67% | |
| 22 | INSPINSPIRE MED SYS INC | 1,347,000 | $100.0B | 1427.13% | |
| 23 | —ARQULE INC | 5,000,000 | $99.8B | 1424.83% | |
| 24 | ISRGINTUITIVE SURGICAL INC | 167,800 | $99.2B | 1416.19% | |
| 25 | SRPTSAREPTA THERAPEUTICS INC | 766,049 | $98.9B | 1411.28% | |
| 26 | DHRDANAHER CORPORATION | 638,900 | $98.1B | 1399.96% | |
| 27 | BHCBAUSCH HEALTH COS INC | 3,183,100 | $95.2B | 1359.70% | |
| 28 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 1,514,171 | $94.2B | 1345.48% | |
| 29 | GKOSGLAUKOS CORP | 1,547,646 | $84.3B | 1203.54% | |
| 30 | PTCTPTC THERAPEUTICS INC | 1,729,200 | $83.1B | 1185.74% | |
| 31 | NTRANATERA INC | 2,440,613 | $82.2B | 1173.90% | |
| 32 | REGNREGENERON PHARMACEUTICALS | 209,300 | $78.6B | 1121.99% | |
| 33 | ARVNARVINAS INC | 1,898,800 | $78.0B | 1113.91% | |
| 34 | QUREUNIQURE NV | 1,081,765 | $77.5B | 1106.73% | |
| 35 | TMOTHERMO FISHER SCIENTIFIC INC | 220,500 | $71.6B | 1022.71% | |
| 36 | MGTXMEIRAGTX HOLDINGS PLC | 3,453,020 | $69.1B | 986.95% | |
| 37 | TNDMTANDEM DIABETES CARE INC | 1,141,390 | $68.0B | 971.37% | |
| 38 | EX9EXELIXIS INC | 3,753,700 | $66.1B | 944.27% | |
| 39 | ABTABBOTT LABS | 715,100 | $62.1B | 886.79% | |
| 40 | HZNPHORIZON THERAPEUTICS PUB LTD | 1,582,300 | $57.3B | 817.76% | |
| 41 | KRYSKRYSTAL BIOTECH INC | 994,808 | $55.1B | 786.54% | |
| 42 | BLUBELLUS HEALTH INC NEW | 7,025,832 | $53.1B | 758.63% | |
| 43 | DC4DEXCOM INC | 234,900 | $51.4B | 733.57% | |
| 44 | CRNXCRINETICS PHARMACEUTICALS IN | 2,039,282 | $51.2B | 730.49% | |
| 45 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 4,342,190 | $50.0B | 714.16% | |
| 46 | AUPHAURINIA PHARMACEUTICALS INC | 2,345,447 | $47.5B | 678.42% | |
| 47 | CRSPCRISPR THERAPEUTICS AG | 766,378 | $46.7B | 666.39% | |
| 48 | —LOGICBIO THERAPEUTICS INC | 6,466,783 | $46.6B | 664.75% | |
| 49 | PRTAPROTHENA CORP PLC | 2,902,239 | $45.9B | 655.91% | |
| 50 | ATNXEURATHENEX INC | 2,772,221 | $42.3B | 604.37% | |
| 51 | ARGXARGENX SE | 256,300 | $41.1B | 587.36% | |
| 52 | TELATELA BIO INC | 3,027,542 | $39.2B | 559.75% | |
| 53 | CRVSCORVUS PHARMACEUTICALS INC | 6,767,584 | $36.8B | 525.62% | |
| 54 | —HARPOON THERAPEUTICS INC | 2,446,409 | $36.2B | 516.57% | |
| 55 | ELVANTHEM INC | 106,600 | $32.2B | 459.66% | |
| 56 | AMGNAMGEN INC | 122,100 | $29.4B | 420.24% | |
| 57 | HCAHCA HEALTHCARE INC | 190,000 | $28.1B | 400.95% | |
| 58 | IQVIQVIA HLDGS INC | 175,000 | $27.0B | 386.03% | |
| 59 | APLTAPPLIED THERAPEUTICS INC | 987,186 | $26.9B | 384.48% | |
| 60 | ZBHZIMMER BIOMET HLDGS INC | 178,700 | $26.7B | 381.88% | |
| 61 | VRCAVERRICA PHARMACEUTICALS INC | 1,479,733 | $23.5B | 335.69% | |
| 62 | XBISPDR SERIES TRUST | 237,200 | $22.6B | 322.09% | Call |
| 63 | PHGEBIOMX INC | 2,313,489 | $22.4B | 319.89% | |
| 64 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 2,865,524 | $21.9B | 312.56% | |
| 65 | ZLABZAI LAB LTD | 514,000 | $21.4B | 305.20% | |
| 66 | GILDGILEAD SCIENCES INC | 326,100 | $21.2B | 302.53% | |
| 67 | ALCALCON INC | 351,380 | $19.9B | 284.47% | |
| 68 | SCPHSCPHARMACEUTICALS INC | 3,409,865 | $19.3B | 275.54% | |
| 69 | BIIBBIOGEN INC | 64,500 | $19.1B | 273.25% | |
| 70 | NVONOVO-NORDISK A S | 330,000 | $19.1B | 272.69% | |
| 71 | AVTRAVANTOR INC | 1,012,800 | $18.4B | 262.44% | |
| 72 | SVASINOVAC BIOTECH LTD | 2,839,500 | $17.2B | 244.86% | |
| 73 | XTNTXTANT MED HLDGS INC | 9,207,012 | $14.7B | 210.31% | |
| 74 | NVLSEURALPINE IMMUNE SCIENCES INC | 3,670,955 | $14.1B | 201.25% | |
| 75 | —AVROBIO INC | 634,700 | $12.8B | 182.42% | |
| 76 | KALAKALA PHARMACEUTICALS INC | 3,447,840 | $12.7B | 181.64% | |
| 77 | KPTIEURKARYOPHARM THERAPEUTICS INC | 621,900 | $11.9B | 170.21% | |
| 78 | —MERSANA THERAPEUTICS INC | 2,073,319 | $11.9B | 169.61% | |
| 79 | ASNSUSDX4 PHARMACEUTICALS INC | 1,086,493 | $11.6B | 165.97% | |
| 80 | XLVSELECT SECTOR SPDR TR | 113,200 | $11.5B | 164.63% | |
| 81 | —NEOLEUKIN THERAPEUTICS INC | 900,000 | $11.1B | 158.30% | |
| 82 | —OBSEVA SA | 2,605,531 | $10.0B | 142.10% | |
| 83 | —FOAMIX PHARMACEUTICALS LTD | 2,577,982 | $8.6B | 122.57% | |
| 84 | OPHTEURIVERIC BIO INC | 1,000,000 | $8.6B | 122.50% | |
| 85 | XENEXENON PHARMACEUTICALS INC | 634,812 | $8.3B | 118.81% | |
| 86 | EPIEURESSA PHARMA INC | 1,471,853 | $8.1B | 115.57% | |
| 87 | CTIC1USDCTI BIOPHARMA CORP | 5,000,000 | $7.9B | 112.79% | |
| 88 | —RESTORBIO INC | 4,830,387 | $7.2B | 102.75% | |
| 89 | VRNAVERONA PHARMA PLC | 1,250,396 | $7.2B | 102.65% | |
| 90 | SELBUSDSELECTA BIOSCIENCES INC | 2,879,064 | $6.9B | 97.83% | |
| 91 | —PFENEX INC | 614,868 | $6.8B | 96.38% | |
| 92 | —APTOSE BIOSCIENCES INC | 1,150,000 | $6.5B | 93.10% | |
| 93 | —ZOGENIX INC | 125,000 | $6.5B | 93.03% | Call |
| 94 | ISIIONIS PHARMACEUTICALS INC | 106,900 | $6.5B | 92.20% | |
| 95 | HCATHEALTH CATALYST INC | 179,598 | $6.2B | 88.97% | |
| 96 | —NABRIVA THERAPEUTICS PLC | 4,644,600 | $6.1B | 87.53% | |
| 97 | ANABANAPTYSBIO INC | 375,800 | $6.1B | 87.19% | |
| 98 | MISTMILESTONE PHARMACEUTICALS IN | 364,206 | $5.8B | 83.25% | |
| 99 | XLRNACCELERON PHARMA INC | 107,500 | $5.7B | 81.38% | |
| 100 | ATRCATRICURE INC | 168,621 | $5.5B | 78.27% |
Page 1 of 2Next